Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04878 | 33470710 | Eur J Gastroenterol Hepatol | Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and diet? | 2021 | Details |
| A04896 | 33461969 | BMJ | Management of non-alcoholic fatty liver disease. | 2021 | Details |
| A04906 | 33456595 | J Med Life | Transgenerational Effects of Traumatic Historical Events on the Incidence of Metabolic Syndrome/ Nonalcoholic Fatty Liver Disease in the Romanian Population. | 2021 | Details |
| A04913 | 33453067 | Liver Int | From NAFLD to MAFLD: Nurse and allied health perspective. | 2021 | Details |
| A04921 | 33448929 | J Med Internet Res | Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping. | 2021 | Details |
| A04924 | 33447122 | Clin Med Insights Endocrinol Diabetes | Oral GLP1 Analog: Where Does the Tide Go? | 2020 | Details |
| A04939 | 33443240 | Minerva Gastroenterol Dietol | Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration. | 2020 | Details |
| A04964 | 33436935 | Sci Rep | Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B. | 2021 | Details |
| A04976 | 33430929 | Chin Med | Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. | 2021 | Details |
| A04977 | 33429859 | Nutrients | Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity. | 2021 | Details |
| A04982 | 33426569 | J Med Syst | Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. | 2021 | Details |
| A04991 | 33422007 | BMC Gastroenterol | Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study. | 2021 | Details |
| A05008 | 33413060 | Curr Med Chem | Lipid Metabolism and Relevant Disorders to Female Reproductive Health. | 2021 | Details |
| A05035 | 33399334 | Nurse Pract | Dietary approaches to managing nonalcoholic fatty liver disease. | 2021 | Details |
| A05040 | 33397443 | Biol Sex Differ | Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. | 2021 | Details |
| A05052 | 33392801 | Curr Atheroscler Rep | Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel? | 2021 | Details |
| A05080 | 33385317 | J Dig Dis | Efficacy and safety of drugs for nonalcoholic steatohepatitis. | 2021 | Details |
| A05092 | 33379253 | Nutrients | Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial. | 2020 | Details |
| A05105 | 33374554 | Nutrients | Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05112 | 33371482 | Biomolecules | Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. | 2020 | Details |
| A05172 | 33346905 | Protein Cell | The role of the gut microbiome and its metabolites in metabolic diseases. | 2020 | Details |
| A05213 | 33336648 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. | 2020 | Details |
| A05218 | 33334622 | Arch Med Res | Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05231 | 33330100 | Front Oncol | Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. | 2020 | Details |
| A05240 | 33327438 | Int J Mol Sci | Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05243 | 33327227 | Medicine (Baltimore) | Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria. | 2020 | Details |
| A05249 | 33324348 | Front Endocrinol (Lausanne) | Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. | 2020 | Details |
| A05287 | 33312420 | World J Hepatol | Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo. | 2020 | Details |
| A05307 | 33307021 | Gastroenterology | AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A05312 | 33305889 | Pediatr Obes | The relationship between excessive dietary fructose consumption and paediatric fatty liver disease. | 2020 | Details |
| A05338 | 33297922 | CNS Neurol Disord Drug Targets | Liver-Brain Axis in Sporadic Alzheimer's Disease: Role of Ten Signature Genes in a Mouse Model. | 2021 | Details |
| A05409 | 33268944 | World J Gastroenterol | Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. | 2020 | Details |
| A05515 | 33220489 | Mol Metab | Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease. | 2020 | Details |
| A05532 | 33217052 | J Gastroenterol Hepatol | A review of non-alcoholic fatty liver disease in non-obese and lean individuals. | 2020 | Details |
| A05546 | 33212947 | Nutrients | Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05573 | 33203174 | Nutrients | Nutraceutical Properties of Polyphenols against Liver Diseases. | 2020 | Details |
| A05575 | 33202851 | Antioxidants (Basel) | Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. | 2020 | Details |
| A05576 | 33202693 | Int J Mol Sci | IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05587 | 33198247 | Nutrients | Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05643 | 33177712 | Nature | A reference map of potential determinants for the human serum metabolome. | 2020 | Details |
| A05654 | 33171747 | Int J Mol Sci | The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05683 | 33160101 | Mol Metab | Genetic and epigenetic factors determining NAFLD risk. | 2020 | Details |
| A05685 | 33159388 | FEBS Open Bio | MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro. | 2020 | Details |
| A05696 | 33152542 | Clin Gastroenterol Hepatol | A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05721 | 33143364 | Int J Mol Sci | DNA Methylation in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05736 | 33139607 | Nutrients | Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? | 2020 | Details |
| A05762 | 33129272 | BMC Gastroenterol | Retrospective analysis of a dedicated care pathway for nonalcoholic fatty liver disease in an integrated US healthcare system demonstrates support of weight management and improved ALT. | 2020 | Details |
| A05770 | 33126313 | Medicine (Baltimore) | The efficacy of Qigong exercises for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
| A05830 | 33104787 | Phys Ther | Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions. | 2021 | Details |
| A05835 | 33102800 | Endocrinol Diabetes Metab | Perspectives on youth-onset nonalcoholic fatty liver disease. | 2020 | Details |
| A05851 | 33101626 | Frontline Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. | 2019 | Details |
| A05860 | 33098023 | Dig Dis Sci | Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05864 | 33096115 | Life Sci | The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. | 2020 | Details |
| A05896 | 33083258 | J Clin Transl Hepatol | Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. | 2020 | Details |
| A05901 | 33081177 | Nutrients | Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. | 2020 | Details |
| A05903 | 33080906 | Medicina (Kaunas) | Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. | 2020 | Details |
| A05959 | 33061687 | Hepat Med | Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A05976 | 33053981 | Zhonghua Gan Zang Bing Za Zhi | [Physical activity intervention for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A05991 | 33049668 | Front Biosci (Landmark Ed) | Current treatment paradigms and emerging therapies for NAFLD/NASH. | 2021 | Details |
| A06002 | 33042004 | Front Endocrinol (Lausanne) | Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity. | 2020 | Details |
| A06039 | 33031970 | Ann Hepatol | Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06047 | 33029058 | J Clin Exp Hepatol | Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different? | 2020 | Details |
| A06074 | 33015726 | Curr Diab Rep | Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06118 | 32998725 | BMC Med | Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. | 2020 | Details |
| A06148 | 32987175 | Ann Hepatol | Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases. | 2020 | Details |
| A06154 | 32984925 | Curr HIV/AIDS Rep | NASH in HIV. | 2020 | Details |
| A06164 | 32981386 | Expert Rev Clin Pharmacol | The pharmacological treatment of nonalcoholic fatty liver disease in children. | 2020 | Details |
| A06185 | 32977255 | Nutr Res | High carbohydrate and noodle/meat-rich dietary patterns interact with the minor haplotype in the 22q13 loci to increase its association with non-alcoholic fatty liver disease risk in Koreans. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06216 | 32964202 | JHEP Rep | Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. | 2020 | Details |
| A06217 | 32964201 | JHEP Rep | The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. | 2020 | Details |
| A06227 | 32961669 | Nutrients | Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A06228 | 32961610 | J Diabetes Investig | Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. | 2020 | Details |
| A06242 | 32954243 | JHEP Rep | Stratification of patients in NASH clinical trials: A pitfall for trial success. | 2020 | Details |
| A06245 | 32952877 | World J Hepatol | Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. | 2020 | Details |
| A06246 | 32952876 | World J Hepatol | Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. | 2020 | Details |
| A06264 | 32947869 | Biomolecules | Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. | 2020 | Details |
| A06279 | 32943747 | Sci Rep | Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. | 2020 | Details |
| A06286 | 32941676 | J Clin Hypertens (Greenwich) | Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. | 2020 | Details |
| A06300 | 32936098 | J R Coll Physicians Edinb | Diagnosis and management of fatty liver. | 2020 | Details |
| A06317 | 32931760 | Am J Med | The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective. | 2020 | Details |
| A06329 | 32926803 | Am J Respir Crit Care Med | Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial. | 2021 | Details |
| A06398 | 32893456 | Obesity (Silver Spring) | A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD. | 2020 | Details |
| A06402 | 32892401 | Scand J Immunol | Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD). | 2020 | Details |
| A06422 | 32885579 | Liver Int | Association between consumption of edible seaweeds and newly diagnosed non-alcohol fatty liver disease: The TCLSIH Cohort Study. | 2021 | Details |
| A06441 | 32880109 | Rev Med Suisse | [NASH: new terminology and what else is new in 2020]. | 2020 | Details |
| A06449 | 32878486 | Expert Rev Gastroenterol Hepatol | Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? | 2020 | Details |
| A06460 | 32872238 | Nutrients | Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06466 | 32869884 | J Food Biochem | Remedial role of exercise training to deep-fried oil-induced metabolic and histological changes in Wistar rats. | 2020 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06473 | 32865925 | Int J Med Mushrooms | Pharmacological Investigation of Ceraceomyces tessulatus (Agaricomycetes) in Mice with Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06486 | 32860311 | Liver Int | The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men. | 2021 | Details |
| A06535 | 32833701 | Curr Opin Clin Nutr Metab Care | Lifestyle interventions affecting hepatic fatty acid metabolism. | 2020 | Details |
| A06544 | 32832391 | J Clin Transl Hepatol | Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise. | 2020 | Details |
| A06555 | 32825982 | J Bodyw Mov Ther | Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease. | 2020 | Details |
| A06564 | 32824337 | Int J Mol Sci | History of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06571 | 32823604 | J Clin Med | Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998-2035. | 2020 | Details |
| A06590 | 32816619 | Gut Microbes | Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. | 2020 | Details |